Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MHB046C in Advanced Solid Tumors
NCT06985355Phase 2Recruiting
- Sponsor
- Minghui Pharmaceutical, Inc.
- Start
- Jul 2025
- Primary completion
- May 2029
- Countries
- 1
01
Overview
A Phase 2 trial of MHB046C in solid tumor, sponsored by Minghui Pharmaceutical, Inc.. Started Jul 2025; status: recruiting.
02
Drugs
MHB046C
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT06985355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06985355.